Healthcare provider profile · identity verified

Michelle S Duran, MD

Family Practice · PUEBLO, CO · NPI 1942242821

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	394	110
Atorvastatin Calcium	Atorvastatin Calcium	377	109
Lisinopril	Lisinopril	298	87
Losartan Potassium	Losartan Potassium	261	77
Omeprazole	Omeprazole	245	83
Rosuvastatin Calcium	Rosuvastatin Calcium	219	69
Simvastatin	Simvastatin	210	59
Metformin Hcl	Metformin Hcl	208	58
Amlodipine Besylate	Amlodipine Besylate	182	57
Oxycodone Hcl	Oxycodone Hcl	165	17
Gabapentin	Gabapentin	152	40
Hydrochlorothiazide	Hydrochlorothiazide	141	46
Glipizide	Glipizide	128	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	21
Trazodone Hcl	Trazodone Hcl	123	43
Albuterol Sulfate Hfa	Albuterol Sulfate	115	58
Duloxetine Hcl	Duloxetine Hcl	109	33
Mirtazapine	Mirtazapine	106	32
Tamsulosin Hcl	Tamsulosin Hcl	106	37
Sertraline Hcl	Sertraline Hcl	98	34
Tramadol Hcl	Tramadol Hcl	98	20
Metoprolol Tartrate	Metoprolol Tartrate	88	26
Pantoprazole Sodium	Pantoprazole Sodium	83	35
Meloxicam	Meloxicam	80	24
Metformin Hcl Er	Metformin Hcl	80	23
Metoprolol Succinate	Metoprolol Succinate	79	29
Furosemide	Furosemide	78	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	23
Pradaxa	Dabigatran Etexilate Mesylate	76	22
Citalopram Hbr	Citalopram Hydrobromide	72	23
Alendronate Sodium	Alendronate Sodium	64	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	17
Atenolol	Atenolol	60	19
Ozempic	Semaglutide	60	suppressed
Allopurinol	Allopurinol	58	17
Humulin N	Insulin Nph Human Isophane	57	21
Potassium Chloride	Potassium Chloride	57	18
Spironolactone	Spironolactone	57	18
Escitalopram Oxalate	Escitalopram Oxalate	56	21
Wixela Inhub	Fluticasone Propion/Salmeterol	55	21
Lorazepam	Lorazepam	54	12
Solifenacin Succinate	Solifenacin Succinate	53	22
Tizanidine Hcl	Tizanidine Hcl	53	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	52	52
Venlafaxine Hcl Er	Venlafaxine Hcl	49	15
Bupropion Xl	Bupropion Hcl	47	18
Fluoxetine Hcl	Fluoxetine Hcl	47	13
Trospium Chloride	Trospium Chloride	47	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	46	19
Finasteride	Finasteride	44	15
Fluticasone Propionate	Fluticasone Propionate	41	17
Carvedilol	Carvedilol	40	12
Triamcinolone Acetonide	Triamcinolone Acetonide	40	22
Buspirone Hcl	Buspirone Hcl	39	14
Morphine Sulfate Er	Morphine Sulfate	39	suppressed
Nystatin	Nystatin	38	16
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Jardiance	Empagliflozin	37	14
Montelukast Sodium	Montelukast Sodium	36	11
Eliquis	Apixaban	35	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	35	32
Pravastatin Sodium	Pravastatin Sodium	34	11
Alprazolam	Alprazolam	33	suppressed
Estradiol	Estradiol	33	17
Humulin R	Insulin Regular, Human	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	11
Pregabalin	Pregabalin	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	11
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Clonazepam	Clonazepam	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	28	11
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Prednisone	Prednisone	28	22
Azelastine Hcl	Azelastine Hcl	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Diazepam	Diazepam	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	25	25
Baclofen	Baclofen	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Famotidine	Famotidine	24	11
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	24	11
Levetiracetam	Levetiracetam	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	18
Glimepiride	Glimepiride	23	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Cefuroxime	Cefuroxime Axetil	20	16
Nifedipine Er	Nifedipine	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	20	suppressed
Alvesco	Ciclesonide	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	15
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Lactulose	Lactulose	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Fluconazole	Fluconazole	14	12
Lovastatin	Lovastatin	14	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	suppressed
Budesonide Dr	Budesonide	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Temazepam	Temazepam	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Famciclovir	Famciclovir	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error